GMED
GLOBUS MEDICAL INC
-0.26 (-0.35%)75.00USD396K成交股數10.1B市值19.3本益比(近四季)3.2股價營收比+5.9%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 790M+32% | 760M+16% | 769M+23% | 745M+18% | 598M-1% | 657M+71% | 626M+115% | 630M+128% | 607M | 384M | 292M | 277M |
| 營業成本 | 241M | 234M | 253M | 249M | 195M | 263M | 271M | 260M | 241M | 135M | 76.5M | 70.8M |
| 毛利 | 548M+36% | 526M+33% | 517M+45% | 497M+34% | 403M+10% | 394M+59% | 355M+65% | 370M+80% | 365M | 248M | 215M | 206M |
| 毛利率 | 69.4% | 69.2% | 67.2% | 66.6% | 67.3% | 59.9% | 56.8% | 58.7% | 60.2% | 64.7% | 73.8% | 74.4% |
| 研發費用 | 36.3M | 36.5M | 38.1M | 40.0M | 33.1M | 33.4M | 35.4M | 37.7M | 57.3M | 29.3M | 21.3M | 21.1M |
| 銷售管理費用 | 287M | 298M | 314M | 304M | 243M | 253M | 240M | 239M | 249M | 156M | 120M | 122M |
| 營業利益 | 182M+88% | 150M+150% | 137M+186% | 76.1M+53% | 97.0M+1113% | 60.3M+14819% | 48.1M-27% | 49.6M-12% | 8.0M | 404K | 66.2M | 56.4M |
| 營業利益率 | 23.1% | 19.8% | 17.9% | 10.2% | 16.2% | 9.2% | 7.7% | 7.9% | 1.3% | 0.1% | 22.7% | 20.4% |
| 稅後淨利 | 152M+101% | 124M+369% | 119M+130% | 203M+539% | 75.5M-1160% | 26.5M+2556% | 51.8M-10% | 31.8M-35% | −7.1M | 998K | 57.7M | 49.1M |
| 淨利率 | 19.2% | 16.4% | 15.5% | 27.2% | 12.6% | 4.0% | 8.3% | 5.0% | -1.2% | 0.3% | 19.8% | 17.8% |
| 稀釋 EPS | 1.10+104% | 0.90+374% | 0.88+132% | 1.49+548% | 0.54-1180% | 0.19+1800% | 0.38-33% | 0.23-52% | -0.05 | 0.01 | 0.57 | 0.48 |
| 稀釋股數 | 137M | 138M | 135M | 136M | 140M | 138M | 138M | 137M | 135M | 115M | 102M | 102M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 508M | 561M | 372M | 229M | 461M | 784M | 623M | 410M | 354M | 280M | 306M | 218M |
| 應收帳款 | 692M | 686M | 619M | 612M | 535M | 558M | 588M | 612M | 534M | 494M | 240M | 223M |
| 存貨 | 811M | 773M | 772M | 772M | 664M | 659M | 718M | 770M | 816M | 905M | 336M | 321M |
| 總資產 | 5.5B | 5.4B | 5.1B | 5.0B | 4.7B | 5.3B | 5.1B | 5.0B | 4.9B | 5.4B | 2.2B | 2.1B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 720M | 707M | 697M | 665M | 623M | 1.1B | 1.0B | 1.0B | 1.0B | 1.2B | 227M | 235M |
| 股東權益 | 4.8B | 4.7B | 4.4B | 4.3B | 4.1B | 4.2B | 4.1B | 4.0B | 3.9B | 4.2B | 2.0B | 1.9B |
| 負債比 | 13.1% | 13.0% | 13.7% | 13.4% | 13.2% | 20.5% | 20.0% | 20.4% | 20.7% | 21.8% | 10.3% | 10.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 202M | – | – | 177M+238% | – | – | – | 52.4M | – | – | 53.3M |
| 資本支出 | – | 39.6M | – | – | 36.1M | – | – | – | 28.6M | – | – | 16.0M |
| 自由現金流 | – | 163M | – | – | 141M+493% | – | – | – | 23.8M | – | – | 37.3M |
| 折舊攤銷 | – | 69.9M | – | – | 65.7M | – | – | – | 55.3M | – | – | 18.1M |
| 買回庫藏股 | – | 0.00 | – | – | 190M | – | – | – | 83.3M | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 21.4% | – | – | 23.6% | – | – | – | 3.9% | – | – | 13.5% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 2.9B
| Reportable | 2.9B | 100.0% | +16.7% |
|---|
地區2025 年度 · 2.9B
| 美國 | 2.4B | 80.6% | +18.4% |
|---|---|---|---|
| 美國以外 | 571M | 19.4% | +10.0% |
產品／服務2025 年度 · 2.9B
| Musculoskeletal Solutions | 2.8B | 95.2% | +18.3% |
|---|---|---|---|
| Enabling Technologies | 141M | 4.8% | -8.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.9B | +16.7% | 538M | 18.3% | 3.92 | 589M |
| FY2024 | 2.5B | +60.6% | 103M | 4.1% | 0.75 | 405M |
| FY2023 | 1.6B | +53.3% | 123M | 7.8% | 1.07 | 165M |
| FY2022 | 1.0B | +6.8% | 190M | 18.6% | 1.85 | 104M |
| FY2021 | 958M | +21.4% | 149M | 15.6% | 1.44 | 219M |
| FY2020 | 789M | +0.5% | 102M | 13.0% | 1.01 | 135M |
| FY2019 | 785M | +10.2% | 155M | 19.8% | 1.52 | 101M |
| FY2018 | 713M | – | 156M | 21.9% | 1.54 | 122M |